Your browser doesn't support javascript.
loading
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Rolfo, Christian; Drilon, Alexander; Hong, David; McCoach, Caroline; Dowlati, Afshin; Lin, Jessica J; Russo, Alessandro; Schram, Alison M; Liu, Stephen V; Nieva, Jorge J; Nguyen, Timmy; Eshaghian, Shahrooz; Morse, Michael; Gettinger, Scott; Mobayed, Mohammad; Goldberg, Sarah; Araujo-Mino, Emilio; Vidula, Neelima; Bardia, Aditya; Subramanian, Janakiraman; Sashital, Deepa; Stinchcombe, Thomas; Kiedrowski, Lesli; Price, Kristin; Gandara, David R.
Afiliação
  • Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai System & Icahn School of Medicine, Mount Sinai, New York, NY, USA. christian.rolfo@mssm.edu.
  • Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hong D; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • McCoach C; University of California, San Francisco, CA, USA.
  • Dowlati A; Genentech, South San Francisco, CA, USA.
  • Lin JJ; University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Russo A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Schram AM; Thoracic Oncology & Experimental Therapeutics Program, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Liu SV; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nieva JJ; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Nguyen T; Keck School of Medicine of USC, Section Head - Solid Tumors, USC/Norris Cancer Center, Los Angeles, CA, USA.
  • Eshaghian S; University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Morse M; James R. Berenson, MD, Inc., West Hollywood, CA, USA.
  • Gettinger S; Duke Cancer Institute, Division of Medical Oncology, Durham, NC, USA.
  • Mobayed M; Yale Comprehensive Cancer Center, New Haven, CT, USA.
  • Goldberg S; ProMedica Bay Park Hospital Cancer, Sylvania, OH, USA.
  • Araujo-Mino E; Yale Comprehensive Cancer Center, New Haven, CT, USA.
  • Vidula N; Kymera Cancer Center and University of New Mexico, Roswell, NM, USA.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Subramanian J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Sashital D; Saint Lukes Cancer Institute/University of Missouri, Kansas City, MO, USA.
  • Stinchcombe T; US Oncology Network, Texas Oncology, Baytown, TX, USA.
  • Kiedrowski L; Duke Cancer Institute, Division of Medical Oncology, Durham, NC, USA.
  • Price K; Guardant Health, Redwood City, CA, USA.
  • Gandara DR; Guardant Health, Redwood City, CA, USA.
Br J Cancer ; 126(3): 514-520, 2022 02.
Article em En | MEDLINE | ID: mdl-34480094
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Biomarcadores Tumorais / Proteínas de Fusão Oncogênica / Receptor trkA / Sequenciamento de Nucleotídeos em Larga Escala / DNA Tumoral Circulante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Biomarcadores Tumorais / Proteínas de Fusão Oncogênica / Receptor trkA / Sequenciamento de Nucleotídeos em Larga Escala / DNA Tumoral Circulante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos